Email this article DEPLETION OF OVARIAN RESERVE IN EXTERNAL ENDOMETRIOSIS - NOT A SENTENCE
- Authors: Kalseidova K.S.1, Bakhtiyarov K.R1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 6, No 2 (2019)
- Pages: 110-112
- Section: Original study articles
- URL: https://ogarev-online.ru/2313-8726/article/view/43008
- DOI: https://doi.org/10.18821/2313-8726-2019-6-2-110-112
- ID: 43008
Cite item
Full Text
Abstract
Endomeriosis is rightly called a mystery of the XXI century. In some cases, this disease requires constant monitoring and treatment. This clinical case demonstrates the outcome of multiple surgical treatment of ovarian endometriosis - a spontaneous, long-awaited pregnancy that occurred 2 years after signs of an exhausted ovarian reserve.
Full Text
##article.viewOnOriginalSite##About the authors
Kristina Sh. Kalseidova
I.M. Sechenov First Moscow State Medical University
Email: Kalseidova-k@yandex.ru
6th-year student of I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation Moscow, 119991, Russian Federation
K. R Bakhtiyarov
I.M. Sechenov First Moscow State Medical UniversityMoscow, 119991, Russian Federation
References
- Вroekmans F.J., Kwee J., Hendriks D.J., Mol B.W., Lambalk C.B. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update. 2006;12: 685-718.
- Loh J.S., Maheshwari A. Anti-Mullerian hormone - is it a crystal ball for predicting ovarian ageing? Hum. Reprod. 2011; 26: 2925-32.
- Nelson S.M. Biomarkers of ovarian response: current and future applications. Fertil. Steril. 2013; 99: 963-9.
- Majumder K., Gelbaya T.A., Laing I., Nardo L.G. The use of anti-Mullerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010; 150: 166-70.
- La Marca A., Sighinolfi G., Radi D., Argento C., Baraldi E., Artenisio A.C. et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum. Reprod. Update. 2010; 16: 113-30.
- Iwase A., Nakamura T., Nakahara T., Goto M., Kikkawa F. Anti-Mullerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod. Sci. 2015; 22(5): 519-26.
- Lambalk C.B., van Disseldorp J., de Koning C.H., Broekmans F.J. Testing ovarian reserve to predict age at menopause. Maturitas. 2009; 63 (4): 280-91.
- Henry N.L., Xia R., Schott A.F., McConnell D., Banerjee M., Hayes D.F. Prediction of postchemotherapy ovarian function using markers of ovarian reserve. Oncologist. 2014; 19(1): 68-74.
- Somigliana E., Vercellini P., Vigano P., Ragni G., Crosignani P.G. Should endometriomas be treated before IVF-ICSI cycles? Hum. Reprod. Update. 2006; 12: 57-64.
Supplementary files
